| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | Nov 08, 2023 | Sale | $0.33 | 3,163 | 1,044 | 25,732 | Nov 08, 2023, 08:32 PM | |
| EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | Nov 08, 2023 | Sale | $0.33 | 3,103 | 1,024 | 16,984 | Nov 08, 2023, 08:32 PM | |
| EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | Nov 08, 2023 | Sale | $0.33 | 172 | 57 | 17,758 | Nov 08, 2023, 08:31 PM | |
| EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | Nov 08, 2023 | Sale | $0.33 | 1,811 | 598 | 22,259 | Nov 08, 2023, 08:31 PM | |
| EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | Nov 02, 2023 | Sale | $0.33 | 6,854 | 2,262 | 22,270 | Nov 03, 2023, 04:12 PM | |
| EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | Nov 02, 2023 | Sale | $0.33 | 6,854 | 2,262 | 13,587 | Nov 03, 2023, 04:11 PM | |
| EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | Nov 02, 2023 | Sale | $0.33 | 3,999 | 1,320 | 17,570 | Nov 03, 2023, 04:11 PM | |
| EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | Sep 28, 2023 | Sale | $3.94 | 1,996 | 7,864 | 16,758 | Sep 29, 2023, 04:02 PM | |
| EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | Aug 08, 2023 | Sale | $9.51 | 3,128 | 29,747 | 16,624 | Aug 09, 2023, 08:44 PM | |
| EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | Aug 08, 2023 | Sale | $9.51 | 342 | 3,252 | 3,754 | Aug 09, 2023, 08:43 PM | |
| EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | Aug 08, 2023 | Sale | $9.51 | 3,434 | 32,657 | 7,941 | Aug 09, 2023, 08:42 PM | |
| EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | Aug 08, 2023 | Sale | $9.51 | 2,004 | 19,058 | 9,069 | Aug 09, 2023, 08:42 PM | |
| EVLO | Evelo Biosciences, Inc. | Flagship Pioneering Fund VII, L.P. | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 3,246,753 | 7,499,999 | 3,931,685 | Jul 13, 2023, 05:15 PM | |
| EVLO | Evelo Biosciences, Inc. | AFEYAN NOUBAR | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 1,082,251 | 2,500,000 | 1,461,795 | Jul 13, 2023, 05:15 PM | |
| EVLO | Evelo Biosciences, Inc. | Flagship Pioneering Fund VII, L.P. | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 1,082,251 | 2,500,000 | 1,493,241 | Jul 13, 2023, 05:15 PM | |
| EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | May 23, 2023 | Sale | $0.14 | 22,571 | 3,201 | 262,557 | Jun 12, 2023, 04:01 PM | |
| EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | May 08, 2023 | Sale | $0.13 | 66,730 | 8,375 | 97,516 | May 10, 2023, 09:32 PM | |
| EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | May 08, 2023 | Sale | $0.13 | 68,014 | 8,536 | 285,128 | May 10, 2023, 09:31 PM | |
| EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | May 08, 2023 | Sale | $0.13 | 38,531 | 4,836 | 91,469 | May 10, 2023, 09:31 PM | |
| EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | May 08, 2023 | Sale | $0.13 | 3,537 | 444 | 58,512 | May 10, 2023, 09:31 PM | |
| EVLO | Evelo Biosciences, Inc. | Plinio Mark D. | Chief Commercial Officer | Jan 31, 2023 | Option Exercise | $0.88 | 1,250 | 1,100 | 3,750 | Feb 02, 2023, 04:10 PM | |
| EVLO | Evelo Biosciences, Inc. | CARRIERE STEPHEN J | Principal Accounting Officer | Jan 23, 2023 | Sale | $1.06 | 151 | 160 | 203 | Jan 23, 2023, 05:35 PM | |
| EVLO | Evelo Biosciences, Inc. | Plinio Mark D. | Chief Commercial Officer | Jul 29, 2022 | Option Exercise | $1.79 | 1,250 | 2,237 | 2,500 | Oct 14, 2022, 04:24 PM | |
| EVLO | Evelo Biosciences, Inc. | Nutritional Health LTP Fund General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 4,383,561 | 6,399,999 | 7,590,873 | Jun 01, 2022, 07:00 PM | |
| EVLO | Evelo Biosciences, Inc. | Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 1,095,890 | 1,599,999 | 1,887,419 | Jun 01, 2022, 07:00 PM | |
| EVLO | Evelo Biosciences, Inc. | Nutritional Health LTP Fund, L.P. | 10% Owner | May 27, 2022 | Buy | $1.46 | 1,369,863 | 2,000,000 | 5,495,324 | Jun 01, 2022, 07:00 PM | |
| EVLO | Evelo Biosciences, Inc. | AFEYAN NOUBAR | 10% Owner | May 27, 2022 | Buy | $1.46 | 6,849,315 | 10,000,000 | 8,219,791 | Jun 01, 2022, 07:00 PM | |
| EVLO | Evelo Biosciences, Inc. | Nutritional Health LTP Fund General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 13,698,630 | 20,000,000 | 13,698,630 | Jun 01, 2022, 07:00 PM | |
| EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | May 27, 2022 | Buy | $1.46 | 34,246 | 49,999 | 34,246 | May 31, 2022, 04:15 PM | |
| EVLO | Evelo Biosciences, Inc. | Darzi Lord Ara | Director | May 27, 2022 | Buy | $1.46 | 342,465 | 499,999 | 342,465 | May 31, 2022, 04:11 PM | |
| EVLO | Evelo Biosciences, Inc. | Epstein David R | Director | May 27, 2022 | Buy | $1.46 | 17,123 | 25,000 | 84,080 | May 31, 2022, 04:07 PM | |
| EVLO | Evelo Biosciences, Inc. | Plinio Mark D. | Chief Commercial Officer | Jan 31, 2022 | Option Exercise | $4.00 | 1,250 | 5,004 | 1,250 | Feb 01, 2022, 05:31 PM | |
| EVLO | Evelo Biosciences, Inc. | Flagship Ventures Fund IV, L.P. | 10% Owner | Feb 02, 2021 | Buy | $15.00 | 130,000 | 1,950,000 | 4,125,461 | Feb 04, 2021, 05:56 PM | |
| EVLO | Evelo Biosciences, Inc. | Epstein David R | Director | Dec 11, 2020 | Buy | $6.66 | 7,700 | 51,261 | 17,700 | Dec 14, 2020, 05:15 PM | |
| EVLO | Evelo Biosciences, Inc. | Liu Xiaoli Jacqueline | Principal Accounting Officer | Dec 01, 2020 | Sale | $5.17 | 3,000 | 15,510 | 0 | Dec 02, 2020, 04:44 PM | |
| EVLO | Evelo Biosciences, Inc. | Epstein David R | Director | Aug 28, 2020 | Buy | $4.39 | 4,248 | 18,631 | 4,248 | Sep 01, 2020, 04:13 PM | |
| EVLO | Evelo Biosciences, Inc. | Epstein David R | Director | Aug 31, 2020 | Buy | $4.49 | 5,752 | 25,804 | 10,000 | Sep 01, 2020, 04:13 PM | |
| EVLO | Evelo Biosciences, Inc. | AFEYAN NOUBAR | 10% Owner | Jun 29, 2020 | Buy | $3.75 | 4,666,666 | 17,499,998 | 4,079,032 | Jul 01, 2020, 05:24 PM | |
| EVLO | Evelo Biosciences, Inc. | Flagship Ventures Fund IV-Rx, L.P. | 10% Owner | May 11, 2018 | Buy | $16.00 | 281,250 | 4,500,000 | 18,233,403 | May 15, 2018, 08:43 PM | |
| EVLO | Evelo Biosciences, Inc. | AFEYAN NOUBAR | Director | May 11, 2018 | Buy | $16.00 | 281,250 | 4,500,000 | 18,233,403 | May 15, 2018, 08:41 PM |
Menu